CONTRIBUTION OF PHARMACEUTICAL INDUSTRIES IN CORPORATE SOCIAL RESPONSIBILITY(CSR)
Journal: International Journal of Advanced Research (Vol.12, No. 06)Publication Date: 2024-06-10
Authors : Pooja Dangi Thakur;
Page : 671-675
Keywords : Pharmaceutical Companies CSR SDGs Public Health;
Abstract
The pharmaceutical Industries of India are well-positioned and the nation has very strong scientific as well as upgrading technological base. India is home to more than 141.72 crores population and due to this the country has very large domestic market.On the other hand, the Indian government introduced CSR policy which is meant for the companies and industries to minimize the impact of social issues caused by them. In CSR policy, health sector has been taken as an important game changer(Mishra & Swain, 2016). Additionally, the country is working on seventeen Sustainable Development Goals, out of which SDG-3 is based on Good Health and Wellbeing. According to CSR policy 2014, the Pharmaceutical Companies has to spend 2 percent of their average net profit of preceding three years on social sector activities and for Pharma industries, the healthcare and wellbeing of the society is important. The purpose of this paper is to discuss, how pharmaceutical companies are fulfilling their social obligations through CSR initiatives and how the contribution of CSR through Pharma companies is impacting the society.
Other Latest Articles
- TO EVALUATE THE SELECTION PROTOCOL OF CATARACT PATIENTS ADMITTED THROUGH OUTREACH PROGRAMS (EYE CAMPS) UNDERGOING SURGERY IN A TERTIARY CARE CENTER OF CENTRAL INDIA
- INTERNATIONAL NON-GOVERNMENTAL ORGANIZATIONS STRATEGIES AND WEALTH CREATION IN RWANDA A CASE OF RWANDA RED CROSS
- STUDY ON ANATOMICAL CHARACTERIZATION OFCLERODENDRUM QUADRILOCULARE (BLANCO) MERR
- Are DHEAS Levels at Initiation of Ovarian Stimulation Different Between Pregnant and Non-pregnant after In-Vitro-Fertilization? Α Systematic Review and Meta-analysis |Biomedgrid
- A Development of Synthetic Chimeric Peptide Against Human Papillomavirus 16 L1, L2, E6 And E7 PeptidesBased Therapeutic Potential in A Murine Model of Cervical Cancer |Biomedgrid
Last modified: 2024-08-09 18:21:07